These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2260046

  • 1. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G.
    Therapie; 1990; 45(5):441-5. PubMed ID: 2260046
    [Abstract] [Full Text] [Related]

  • 2. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.
    Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G.
    Cephalalgia; 1989 Dec; 9(4):247-53. PubMed ID: 2692838
    [Abstract] [Full Text] [Related]

  • 3. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, Niederberger U, Soyka D.
    Funct Neurol; 1995 Dec; 10(1):27-35. PubMed ID: 7649498
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
    Maissen CP, Ludin HP.
    Schweiz Med Wochenschr; 1991 Oct 26; 121(43):1585-90. PubMed ID: 1947955
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 26; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 26; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 8. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA, Protocol 125 study group.
    Headache; 2004 Jun 26; 44(6):581-6. PubMed ID: 15186302
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS.
    Can J Neurol Sci; 1992 Aug 26; 19(3):340-5. PubMed ID: 1393843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 26; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 12. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 26; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
    Mastrosimone F, Iaccarino C, de Caterina G.
    J Med; 1992 Apr 26; 23(1):1-16. PubMed ID: 1573338
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb 26; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S.
    Headache; 2006 May 26; 46(5):781-7. PubMed ID: 16643581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.